Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Inventory (2021 - 2025)

Macrogenics (MGNX) has disclosed Inventory for 5 consecutive years, with $7.9 million as the latest value for Q4 2025.

  • Quarterly Inventory changed N/A to $7.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.9 million through Dec 2025, changed N/A year-over-year, with the annual reading at $7.9 million for FY2025, N/A changed from the prior year.
  • Inventory for Q4 2025 was $7.9 million at Macrogenics, down from $8.8 million in the prior quarter.
  • The five-year high for Inventory was $9.4 million in Q1 2025, with the low at $1.1 million in Q3 2023.
  • Average Inventory over 5 years is $4.1 million, with a median of $3.2 million recorded in 2024.
  • The sharpest move saw Inventory tumbled 72.71% in 2022, then surged 731.84% in 2025.
  • Over 5 years, Inventory stood at $4.4 million in 2021, then plummeted by 66.93% to $1.5 million in 2022, then decreased by 15.85% to $1.2 million in 2023, then surged by 165.68% to $3.2 million in 2024, then skyrocketed by 143.53% to $7.9 million in 2025.
  • According to Business Quant data, Inventory over the past three periods came in at $7.9 million, $8.8 million, and $9.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.